The humanized mouse models market is booming, projected to reach $1.5 billion by 2033, driven by advancements in drug discovery and the need for accurate preclinical testing. Learn about market trends, key players (Charles River, Taconic Biosciences), and the growing demand for these innovative models in oncology, immunology, and infectious disease research.

Our Clients

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.